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In Vitro Bile-Acid Binding and Fermentation of High, Medium,
and Low Molecular Weight β-Glucan
HYUN JUNG KIM AND PAMELA J. WHITE*
Department of Food Science and Human Nutrition, Iowa State University, Ames, Iowa
The impact of β-glucan molecular weight (MW) on in vitro bile-acid binding and in vitro fermentation
with human fecal flora was evaluated. β-Glucan extracted from oat line ‘N979-5-4’ was treated with
lichenase (1,3-1,4-β-D-glucanase) to yield high (6.87  105 g/mol), medium (3.71  105 g/mol), and
low (1.56  105 g/mol) MW fractions. The low MW β-glucan bound more bile acid than did the high
MW β-glucan (p < 0.05). If the positive control, cholestyramine, was considered to bind bile acid at
100%, the relative bile-acid binding of the original oat flour and the extracted β-glucan with high,
medium, and low MW was 15, 27, 24, and 21%, respectively. Significant effects of high, medium,
and low MW β-glucans on total SCFA were observed compared to the blank without substrate
(p < 0.05). There were no differences in pH changes and total gas production among high, medium,
and low MW β-glucans, and lactulose. The low MW β-glucan produced greater amounts of SCFA
than the high MW after 24 h of fermentation. Among the major SCFA, more propionate was
produced from all MW fractions of extracted β-glucans than from lactulose. In vitro fermentation of
extracted β-glucan fractions with different MW lowered pH and produced SCFA, providing potential
biological function.
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INTRODUCTION
Oats are nutritious food materials, having positive physiolo-
gical effects, including control of blood cholesterol and glucose
levels, andof the insulin response, thus decreasing the incidence of
obesity, heart disease, cancer, and type-2 diabetes (1, 2). The
health benefits of oat-based food products are attributed to the
mixed linkage (1f3)(1f4)-β-D-glucan ( β-glucan), a soluble diet-
ary fiber. The U.S. Food and Drug Administration (FDA)
approved a health claim that oat β-glucan at a level of 3 g per
day may reduce cholesterol and lower the risk of coronary heart
disease (3).
Many mechanisms have been proposed for the cholesterol-
lowering effect derived from the consumption of β-glucan (1, 2,
4). One such mechanism is the ability of β-glucan to lower the
reabsorption of bile acids, thus increasing fecal excretion of bile
acids (5). Bile acids, acidic steroids synthesized in the liver from
cholesterol, are actively reabsorbed by the terminal ileum and
undergo an enterohepatic circulation. By binding bile acids with
β-glucan, cholesterol in the liver can be converted to additional
bile acids which then are excreted, thus reducing cholesterol (5).
In addition, the cholesterol-lowering occurs as a secondary
reaction of microbial fermentation of β-glucan in the large
intestine (1, 6, 7). β-Glucans are not digested in the small
intestines of humans: they are fermented by the colonic
microflora in the large intestine. Fermentation of β-glucan results
in the formation of short-chain fatty acids (SCFA), primarily
acetate, propionate, and butyrate. Propionate, in particular, was
reported to reduce cholesterol by suppressing cholesterol synth-
esis in the liver (6). Also, the low pH in the gut caused by the
production of SCFA can prevent the growth of harmful bacteria
and aid in the absorption of minerals, such as calcium and
magnesium (8).
Viscosity is the key physical characteristic contributed by oat
β-glucan. Two factors influencing the viscosity of solutions are
concentration and MW of β-glucan (2), thus contributing to the
nutritional effects of β-glucan. Wood et al. (9) reported high
correlations between β-glucan concentration in oat and the
viscosity of the solutions. Butt et al. (10) suggested that β-glucan,
in order to be physiologically active, should be soluble, the
concentration and MW should be sufficiently high, and MW
vary between 2.68 104 and 3.24 106 g/mol; however, the role
of β-glucan MW in cholesterol reduction is not well established.
The cholesterol-lowering activity of barley β-glucan occurred at
both high and low MW (11). An animal study showed that the
cholesterol-lowering effect was lost after extensive hydrolysis of
β-glucans (12). Frank et al. (13) also reported that β-glucans with
low MW (2.17  105) and high MW (7.97  105 g/mol) had
similar cholesterol-lowering effects in human subjects consuming
oat breads made with these β-glucan sources. However, some
studies showed cholesterol-lowering effects only from low MW
(0.7  105) β-glucan consumption (14, 15). The inconsistent
results of β-glucanMWon physiological effects is still in question
and needs further investigation.
The objectives in this study were to yield β-glucan extracts with
high, medium, and low MW fractions from an experimental oat
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line developed at Iowa State University, and to determine the
impact of β-glucan MW on in vitro bile-acid binding, solution
viscosity, and in vitro fermentation with human fecal flora by
using β-glucan extracts with the different MW.
MATERIALS AND METHODS
Oat Grain and Oat Flour Preparation. The experimental oat line
‘N979-5-4’, developed at Iowa State University, was used to yield high,
medium, and low MW β-glucan. Oat grain was grown at the Agronomy
and Agricultural Engineering Field Research Center in Ames, IA, and
harvested in 2008. Oats were dried and dehulled with an air-pressure
dehuller (Codema, Eden Prairie, MN). The kernels were ground in an
ultracentrifugal mill (ZM-1, RetchGmbH&Co., Haan, Germany) with a
0.5 mm sieve. Oat flours were then stored in plastic bags at 4 C until used.
Extraction and Hydrolysis of β-Glucan. Oat flours were refluxed
with 82% (v/v) ethanol for 2 h at 85 C to inactivate endogenous enzymes
and to remove fat (4) (Figure 1). Water-soluble β-glucans were extracted
from the treated oat flours by using water with heat-stable R-amylase
(Sigma-Aldrich Co., St. Louis, MO) and pancreatin (Sigma-Aldrich Co.)
according to the procedure of Yao et al. (16). The extracted β-glucan
suspension (defined as high MW β-glucan) was hydrolyzed by using
lichenase (EC 3.2.1.73, Cat No. E-LICHN, Megazyme International Ltd.
Co., Wicklow, Ireland), which is a 1,3-1,4-β-D-glucan-4-glucanohydro-
lase derived from Bacillus subtilis and cleaves the 1,4-linkage of the
3-O-substituted glucose residues in β-glucan, to yield medium and low
MW β-glucan fractions. Lichenase (0.00125 U/g of oat flour to produce
medium-MW β-glucan and 0.01 U/g of oat flour to produce low-MW
β-glucan)was added to the extracted β-glucan suspensionand incubated at
60 C for 20 min. The hydrolyzed β-glucan suspensions were heated in a
boiling water bath for 10 min to inactivate the lichenase. The β-glucan
suspensions with different MW were freeze-dried to produce high,
medium, and low MW β-glucan fractions, respectively (BG-High MW,
BG-Med MW, and BG-Low MW).
Molecular Weight Determination. Relative MW distribution of the
different β-glucan extracts after hydrolysiswith lichenasewere analyzedby
using size-exclusion high-performance liquid chromatography (SE-
HPLC) (16). The SE-HPLC was composed of a solvent delivery module
(model 210, ProStar, Varian Inc., Rheodyne, CA), a 100 μL loop injection
valve, a guard column (Ohpak SB-G, ShodexShowaDenkoK.K., Tokyo,
Japan), three serially connected columns (Ohpak SB-806 HQ, Ohpak SB-
805 HQ and Ohpak SB-804 HQ; Shodex Showa Denko K. K.), and a
refractive index detector (model 350, ProStar, Varian Inc.). Column and
detector were controlled at 40 C. The flow rate of the mobile phase,
Milli-Q water (Millipore, Bedford, MA) containing 0.02% sodium azide
(Sigma-Aldrich Co.), was 0.5 mL/min. Samples were filtered through a
0.45 μm nylon syringe filter (25 mm i.d., Whatman, NJ) before the
injection. β-Glucan MW standards (Cat No. P-MWBGS, Megazyme)
withMWvalues of 3.59 105, 2.45 105, 1.83 105, 1.23 105, and 0.4
105 g/mol were used to estimate the actual MW ranges of high, medium,
and low MW β-glucans. The peak MW and number-average MW (Mn)
were obtained by a first-order polynomial curve of log MW against
retention time. The Mn was calculated by the equation Mn =
P
wi/P
(wi/MWi), where wi was the weight fraction of time  height derived
from the HPLC chromatogram, and MWi was the MW of the ith species
calculated from the standard curve (16).
Proximate Composition.Moisture content of oat flour and extracted
β-glucans was determined by AACC method 44-15A (17). The β-glucan
concentrations in oat flour and extracted β-glucans with high, medium,
and low MW were analyzed enzymatically by AACC method 32-23 by
using a mixed β-glucan linkage kit (Megazyme). Starch content was
analyzed by AACC method 76-13 by using a Total Starch Kit
(Megazyme). Proteins were determined by using an automatic nitrogen
analyzer (Elementar Analzen System GmbH, Germany) with a nitrogen
conversion factor of 6.25. All analyses were run in triplicate and the
average reported on a dry-weight basis (db).
Water Solubility. Water solubility of high, medium and low MW
β-glucan was determined according to the method of Park et al. (18). The
β-glucan dispersion in water (1%, w/v) was agitated at 37 C for
24 h and then centrifuged at 1400g for 20 min. The supernatant was
separated and freeze-dried. The solubility was calculated as the
percentage (%) = (weight of β-glucan dissolved in the supernatant)/
(initial weight of β-glucan in the dispersion)  100.
Viscosity Determination. The apparent viscosity of high, medium,
and low MW β-glucan solutions was determined by using a Rapid Visco-
Analyzer (RVA, Newport Scientific, Warriewood, Australia). Conditions
were a stirring speed of 33.03g for 10 s, followed by stirring at 0.47g for
4 min at 25 C. The peak viscosity and final viscosity were measured. All
pasting curves were collected in duplicate from two slurries, and the
average was reported.
In Vitro Bile-Acid Binding. In vitro bile-acid binding of high,
medium, and low MW β-glucan fractions was measured according to
previous procedures with modification (19,20). The bile acid mixture was
prepared with sodium cholate, sodium deoxycholate, sodium glycocho-
late, and sodium taurocholate (Sigma-Aldrich Co.) with proportions as
35%, 35%, 15%, and 15% (w/w) in 50 mM phosphate buffer at pH 6.9,
respectively. The cholesterol-lowering effects of dietary fiber can be
predicted by evaluating in vitro bile-acid binding compared with choles-
tyramine, a positive control, and cellulose, a negative control (5, 19).
Previous studies showed a positive correlation between in vitro and in vivo
studies and the bile-acid binding impact of these controls (19). The high,
medium, and low MW β-glucans, oat flour, cholestyramine (Sigma-
Aldrich Co.; a bile acid binding anionic resin), and cellulose (Sigma-
Aldrich Co.; a non-bile acid binding fiber) were weighed at 50 mg into
centrifugal tubes. Samples were digested with 1 mL of 0.01 N HCl in a
shakingwater bath at 37 C for 1 h, which simulated gastric digestion. The
sample pHwas adjusted to 6.9 with 0.1NNaOH.To each sample, 4mLof
bile acid mixture (1.4 μmol/mL) and 5 mL of porcine pancreatin (activity
at least equivalent to 8 USP specifications, 6.25 mg/mL in a 50 mM
phosphate buffer, pH 6.9; to provide amylase, protease, and lipase for
digestion) were added and incubated at 37 C for 1 h in a shaking water
bath. Sample mixtures were centrifuged at 3100g for 10 min. The super-
natant was removed. An additional 5 mL of phosphate buffer was used to
rinse out the residue, and themixtureswere centrifuged again. Supernatant
was removed and combined with the previous supernatant. Unbound bile
acid in the supernatant was analyzed by using a Bile Acid Diagnostic Kit
(Trinity Biotech plc, Bray Co.,Wicklow, Ireland). Samples were diluted to
fall within the range of the test kit. The concentration of bile acid was
Figure 1. Preparation of extractedβ-glucan fractions having high,medium
and low MW.
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calculated based on a standard curve developed from the bile acid at
different concentrations.
In Vitro Fermentation. In vitro fermentation of high, medium, and
low MW β-glucan was conducted by a batch fermentation system under
strict anaerobic conditions for 24 hwith human fecal flora by following the
method of Sayar et al. (21). The inoculums were prepared from the fresh
feces collected from two healthy volunteers who had not received
antibiotics for at least 3 months and had not suffered from indigestion
problems within the previous week. It was previously reported that total
bacteria counts and number and distribution of species in the feces were
sufficiently uniform to produce similar in vitro fermentation findings (22).
Also, the previous work of our laboratory reported that different human
feces obtained from three healthy individuals had similar patterns during
in vitro fermentation (23). In this study, the mixture of feces from two
individuals was used for all samples including blank, lactulose, and
extracted β-glucan.
The anaerobic fermentation medium was prepared with brain heart
infusion (Difco Laboratories, Detroit, MI) according to the method of
Zheng et al. (24). The high, medium, and lowMW β-glucanswereweighed
to 100 mg into 50 mL serum bottles. Fermentation medium (8 mL) was
added to each bottle, and the headspace of the bottle was flushed with
CO2. The serum bottles were sealed with PTFE/silicone septa and
aluminum caps (Supelco Inc., Bellefonte, PA). The extracted β-glucans
with high, medium, and low MWwere hydrated overnight at 4 C. Blank
without any substrate and lactulose (Sigma-Aldrich Co.) as a completely
fermentable substrate were prepared as controls. The inoculums were
prepared from fresh feces collected from the volunteers. Feces from two
volunteers were immediately pooled. Each fecal sample was mixed with
three parts of the fermentationmedium and filtered through four layers of
cheesecloth in an Erlenmeyer flask under continuous CO2 flow. 100 mL of
filtrate from two different fecal samples was mixed together. The mixed
filtered inoculums (2 mL) were added to each sample bottle and the
headspace flushed with CO2. The recapped bottles were incubated in a
shakingwater bath at 37 C for 0, 2, 4, 8, 12, and 24h.Total gas production
wasmeasured by the overpressure in the headspace of the bottle by using a
digital manometer (Fisher Scientific, Pittsburgh, PA). Fermentation was
terminated by adding 0.1 mL of saturated mercury chloride solution. The
sample was transferred to a centrifuge tube, and pH was measured. After
centrifugation at 3100g for 10 min, 1 mL of aliquot from the supernatant
was taken for the SCFA analysis.
Shot-Chain Fatty Acids Analysis. The SCFA, such as acetate,
propionate, isobutyrate, butyrate, isobalerate, and valerate, were analyzed
as their silyl derivatives by a gas chromatography (21). The aliquot of
fermentation solution (1mL) wasmixedwith 100 μLof 2-ethylbutyric acid
as an internal standard. Hydrochloric acid (0.5 mL) to protonize the
SCFAanddiethyl ether (3mL)were added andmixedwith a vortexer.One
milliliter of the ether layer was removed and derivatized by 100 μL of
N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide (MTBSTFA;
Sigma Co.) at 80 C for 20 min. After standing at room temperature in
the dark for 24 h for complete derivatization, 1 μL ofmaterial was injected
into a Hewlett-Packard 5890 GC (Hewlett-Packard, Palo Alto, CA). The
column was an SPB-5 (30 m  0.25 mm; Supelco, Inc.), and helium was
used as the carrier gas. The oven temperature was kept at 70 C for 3 min
and programmed to increase to 160 at 7 C/min and stay for 5 min. The
injector and detector temperature were 220 and 250 C, respectively. The
SCFAwere identified and quantifiedby comparisonwithknown fatty acid
standards (Sigma-Aldrich Co.). The reproducibility of the SCFA analysis
by GC was determined by running four replicates of the standards of
acetic, propionic, butyric, and valeric acid. The coefficients of variation for
measuring fatty acids were 1.3-2.1%. The low coefficients of variations
showed that the GC method for the SCFA analysis was reproducible.
Statistical Analysis. Results were analyzed by using the analysis of
variance (ANOVA), followed by Tukey’s test to compare the differences
among treatments by using SPSS version 11.0 (SPSS Inc., Chicago, IL) at
R= 0.05.
RESULTS AND DISCUSSION
Characterization of the Extracted β-Glucans with High, Med-
ium, and Low MW. The extracted β-glucan MW fractions con-
tained 64.1-66.6% of β-glucan, 5-5.8% of starch, and 4-4.5%
of protein (Table 1). Most of the starch and protein in the oat
flours was removed during treatment of β-glucan with R-amylase
and pancreatin. The number-averageMW(Mn) and peakMWof
high, medium, and low MW β-glucan determined from the peak
retention time of the SE-HPLC chromatograms after the hydro-
lysis of β-glucan are shown (Table 1). The Mn of high MW
β-glucan was greatly decreased from 6.87  105 g/mol to 3.71 
105 g/mol (medium MW) and to 1.56  105 g/mol (low MW),
respectively (p< 0.05), depending on the lichenase amount. The
peakMWvalues of high,medium, and lowMWβ-glucandiffered
(p< 0.05). Water-soluble β-glucans previously were reported to
haveMW values in the range from 2 104 to 4 107 g/mol (10).
Even though the MW range of three different fractions of
β-glucan was not great compared to the one previously
reported (10), the Mn and peak MW of high, medium, and low
β-glucanMW fractions were significantly different. The viscosity
(one of the most important characteristics of β-glucan) of three
β-glucan fractions was greatly different as shown in Table 2. We
hypothesized that these ranges of MW of β-glucan could affect
the biological function of β-glucan.
The water solubilities of the extracted high, medium, and low
MW β-glucan were 82.9 ( 4.61, 88.9 ( 2.34, and 91.8 ( 1.95%,
respectively. As the MW of β-glucan decreased, the solubility
increased. β-Glucan with a lowerMWmight bemore mobile and
diffuse more easily compared to a higher MW. Chang et al. (25)
suggested that increased water solubility is a desirable property
for pharmaceutical applications, because it provides an environ-
ment in the gut that enhances physiological activities such as
anticoagulation and antitumorigenesis. The increased water
solubility can also benefit blending of β-glucan into foods,
Table 1. Chemical Composition and Molecular Weight Distributions of the Extracted β-Glucan Fractions with High, Medium, and Low MW
compositiona (%, dry wt basis) MWa (105 g/mol)
β-glucan starch protein Mn
b peak
oat flour 6.75( 0.01 a 54.72( 0.43 a 14.35( 0.10 a 6.87( 0.33 a 9.50( 1.14 a
BG-High MWc 64.14( 2.83 b 5.85( 0.09 b 4.53( 0.11 b 6.87( 0.33 a 9.50( 1.14 a
BG-Med MW 65.07( 3.59 b 5.05( 0.03 c 4.54( 0.14 b 3.71( 0.18 b 5.13( 0.51 b
BG-Low MW 66.60( 2.58 b 5.04( 0.01 c 4.27( 0.24 b 1.56( 0.11 c 2.06( 0.23 c
aValues are means of triplicate determinations. Values with different letters within a column are significantly different (P < 0.05). b Mn, number-average MW.
c BG, extracted
β-glucan. MW, molecular weight.
Table 2. Viscosity of the Extracted β-Glucan Slurries Made with High,
Medium, and Low MW β-Glucan
viscositya (cP)
extracted β-glucan β-glucan (%) in the solution peak final
BG-High MWb 0.52 726( 18 a 700( 45 a
BG-Med MW 0.65 451( 58 b 363( 19 b
BG-Low MW 0.56 121( 2 c 59( 28 c
a Values are means of triplicate determinations. Values with different letters within
a column are significantly different (P < 0.05). b BG, extracted β-glucan. MW,
molecular weight.
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because of the enhanced solubility, and provide more stable
mixtures (17).
Peak and final viscosity of the high, medium, and low MW
β-glucan solutions were determined by using the RVA at 25 C
(Table 2). Viscosity of the solutions increased greatly with higher
MW of β-glucan (p< 0.05). In agreement with these findings, a
greater MW of β-glucan in some oat types caused greater slurry
viscosities than a lowerMW inother oat types (16). Yao et al. (16)
also reported that the substantial contributor of peak viscosity in
oat flour slurries was β-glucan. The enzymatic degradation by
lichenase in medium and lowMW β-glucans selectively degraded
β-glucan and led to modifications in the viscosity of solutions.
In Vitro Bile-Acid Binding. In vitro bile-acid binding of choles-
tyramine, cellulose, oat flour, and high, medium, and low MW
β-glucan on a dry weight basis (db) are shown (Table 3). Chole-
styramine bound 10.00 μmol bile acid/100 mg db, which was equal
to 89.2%of the total addedbile acid.Cellulose as a negative control
bound only 0.03 μmol bile acid/100 mg db, which was 0.2% of the
total added bile acid. These values are similar to the results reported
for cholestyramine and cellulose in the literature (4, 19).
In vitro bile-acid binding values of the oat flour and of the
extracted β-glucan with high, medium, and low MW were 1.51,
2.12, 2.41, and 2.73 μmol bile acid/100 mg oat material db. When
the bile-acid binding value of cholestyramine was 100%, the
relative bile-acid binding values of the oat flour and of the high,
medium, and lowMW β-glucan fractions were 15%, 21%, 24%,
and 27%, respectively. All β-glucan fractions bound more bile
acid than the oat flour (p<0.05). The lowMWandmediumMW
β-glucan bound more bile acid than did the high MW β-glucan.
The bile-acid binding values of the oat flours from different oat
lines and oat bran were in the range of 6% to13.5% (4, 19).
The concentration of β-glucan in the oat flour and the
extracted β-glucan fractions with high, medium, and low MW
were 6.75%, 64.14%, 65.07%, and 66.60%, respectively
(Table 1). The oat flour, with the lowest concentration, had the
greatest bile-acid binding value per amount of β-glucan. The
extracted β-glucans, with about 10-fold higher concentrations of
β-glucan than the oat flour, resulted in lower bile-acid binding per
amount of β-glucan. These data suggest that the oat flour might
have other components besides β-glucan contributing to bile-acid
binding, or that β-glucan might bind more optimally in more
dilute surroundings. Sayar et al. (4) observed no significant
correlations between β-glucan content in oat flours differing in
β-glucan concentrations and bile-acid binding, but significant
correlations between insoluble dietary fiber content from the oat
flour and bile-acid binding. Kahlon and Woodruff (19) reported
that bile-acid binding was related to the insoluble dietary fiber,
not total dietary fiber and soluble dietary fiber. They also
suggested that the primary mechanism of cholesterol-lowering
by oat bran was not caused by the bile-acid binding by its soluble
dietary fiber, such as β-glucan (19). Bowles et al. (26) found that
the cholesterol-lowering property of β-glucan did not involve a
simple binding of bile salt molecules to specific sites on the
β-glucan polymer. The intensity of interactions with bile acid
was affected by the fine structure of both the polysaccharides and
the steroids, as well as by the pH of the media (27, 28). Thus,
further evaluations are needed to explore these hypotheses.
In Vitro Fermentation.The in vitro fermentation progress of the
blank, lactulose, and high, medium, and low MW β-glucans was
monitored by pH changes, gas production, and SCFA formation
during 0, 2, 4, 8, 12, and 24 h of fermentation (Figures 2 and 3).
The pH of all treatments decreased until 4-8 h of fermentation,
when the total gas production generally reached its maximum.
The pH slightly increased until the end of fermentation after 8 h.
These results are consistent with those observed for oat bran and
oat flour (21, 23, 29). The pH of lactulose, which is completely
metabolized in the colon by enteric bacteria, dropped greatly
during fermentation ( p<0.05). The pHof the extracted β-glucan
Table 3. In vitro Bile-Acid Binding by the Extracted β-Glucan Fractions
Containing High, Medium, and Low MW β-Glucan
sample
bile-acid bindinga
(μmol/100 mg sample, db)
bile-acid binding
to total bile acid (%)
cholestyramine 10.00( 0.13 a 89.2
BG-High MWb 2.12( 0.04 c 18.9
BG-Med MW 2.41( 0.12 bc 21.5
BG-Low MW 2.73( 0.09 b 24.3
oat flour 1.51( 0.04 d 13.5
cellulose 0.03( 0.01 e 0.2
aValues are means of replicate determinations. Values with different letters
within a column are significantly different (P < 0.05). b BG, extracted β-glucan. MW,
molecular weight.
Figure 2. The pH changes and total gas production during in vitro fermentation of blank without substrate, lactulose, and the extracted β-glucan fractions
having high, medium, and low MW β-glucan.
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fractions with high, medium and low MW decreased from 6.4
to 5.7-5.8, with no differences among different MW β-glucans
( p> 0.05).
As the fermentation time increased from 0 to 24 h, the total gas
production of the extracted β-glucan fractions with high, med-
ium, and low MW increased (Figure 2). Lactulose and the
β-glucan fractions produced greater amounts of gas than did
the blank (p< 0.05). No significant differences among lactulose
and the β-glucan fractions were found. Total amounts of gas after
24 h of fermentation were about 32-33 mL for lactulose and
β-glucan fractions and 21 mL for the blank. These values were
similar to data from other studies with oat flours, oat bran, and
purified β-glucan (21, 29).
Total SCFA formation, including acetate, propionate, and
butyrate, from the blank, lactulose, and the β-glucan fractions
during in vitro fermentation are shown (Figure 3). The production
of SCFA for all treatments continuously increased as fermenta-
tion time proceeded. Total gas production and SCFA formation
were highly correlated during fermentation (R2 = 0.90). Lactu-
lose, as a standard for complete fermentation in the colon, tended
to produce less SCFA than the β-glucan fractions with high,
medium, and low MW. In previous work, the production of
SCFA from the lactulose was greater than from the digested oat
flour and oat bran (21,29). The extracted β-glucan fractions were
highly fermentable, especially compared to lactulose in the
current study. The lowMW β-glucan produced a greater amount
of SCFA than did the high MW fraction after 24 h of fermenta-
tion (p< 0.05).
Acetate, propionate, and butyrate, the main SCFA formed
from in vitro fermentation, were typical metabolites for dietary
fiber polysaccharide fermentation (21, 29). In addition to the
three main SCFA, small amounts of isobutyrate, valerate, and
isovalerate were produced (<5-7% of the total) from all treat-
ments, which are themajor products of protein fermentation (21).
The amount of acetate, propionate, and butyrate increased but by
different amounts during fermentation (Figure 3). Acetate was
produced in the greatest proportions, followed by butyrate and
propionate.Acetate is themainmetabolite fromwhich the human
body obtains energy out of dietary fiber and is the primary
substrate for cholesterol synthesis (1). The extracted high, med-
ium, and low MW β-glucan produced more propionate than did
lactulose. The lowMW β-glucan producedmore propionate than
did high and medium MW during fermentation (Figure 3). The
production of propionate has been reported to lower blood
Figure 3. TheSCFAproduction during in vitro fermentation of blankwithout substrate, lactulose, and the extractedβ-glucan fraction having high, medium, and
low MW β-glucan.
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glucose and insulin levels (30) and increase high density lipo-
protein (HDL) cholesterol and triglycerides (30, 31). Butyrate is
also physiologically important because of its use for colonic cell
growth and differentiation (1, 32).
Different molecular features of the oat β-glucan affected the
SCFA profile during in vitro fermentation (Figures 2 and 3). The
lowMW β-glucan fraction (shorter chain length) produced more
SCFA than the highMW fraction. Several studies suggested that
compounds with shorter (DP < 10) chain lengths are fermented
more rapidly, with more gas production, than long-chain carbo-
hydrates (33, 34). Fructo-oligosaccharide materials differing in
MW gave different SCFA profiles during fermentation (33). The
water solubility of the extracted β-glucan fractions was in the
order of lowMW>mediumMW>highMW β-glucan (91.8%,
88.9%, and 82.9%, respectively). Perhaps the greater water
solubility of the low MW β-glucan over that of the high or
mediumMW β-glucan resulted in the greater SCFA production.
In other work, different physiological mechanisms were observed
between cereal β-glucan materials with different MW features.
The cholesterol-lowering effect of barley β-glucan in hamsters
occurred with both low (1.75  105 g/mol) and high MW (1.0 
106 g/mol), but lower accumulation of cholesterol esters was
observed with the low-MW β-glucan (11). A low-MW barley
β-glucan did not lower serum cholesterol significantly (35),
whereas 5 g per day of oat β-glucan with a low MW (0.7 
105 g/mol) in a drink lowered serum cholesterol (36). Wood (2)
determined that dispersion or solubilization of the β-glucan was
more important to the physiological effect than was MW.
High (6.87 105 g/mol), medium (3.71 105 g/mol), and low
(1.56  105 g/mol) MW fractions of water-extracted β-glucan
were successfully produced by using lichenase. The lower theMW
of the β-glucan fraction, the lower the viscosity of the solution,
and the greater the in vitro bile-acid binding. In vitro fermentation
of the extracted β-glucan with high, medium, and low MW
lowered pH as a result of the SCFA production. The low-MW
β-glucan produced greater SCFA than the high-MW β-glucan
after 24 h of fermentation. The extracted β-glucans produced
greater amounts of propionate which has great potential for
lowering cholesterol. The impact of the lowMW β-glucan on the
potential biological function maybe related to the high solubility.
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